National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
Rituxan (rih-TUK-sun)

 A monoclonal antibody used to treat certain types of B-cell non-Hodgkin lymphoma. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Rituxan binds to the protein called CD20, which is found on B-cells. Also called rituximab.

Previous Definitions:risedronate, risk factor, risk ratio, ritonavir, ritual
Next Definitions:rituximab, RK-0202, RMP-7, RNA, Ro 31-7453